Generic Drug Industry in Japan: Market Research Reports, Statistics and Analysis

Company Report: Generic Drug In Japan And The United States For Y ...

... Formulations sales have witnessed a strong growth aided largely by continued growth in suprax sales which is yet to witness any generic competition, while sales of antara has remained subdued. Going forward ...

Company Report: Generic Drug In Japan, South Korea And Switzerlan ...

... generic drug penetration in japan. In 2004, the generics share was only 2% - whereas in germany and the usa, the figure was over 30%. This indicates the future potential for generic drugs in japan. Invest ...

Company Report: Generic Drug In Japan For Year 2011

... generic drug specialists from overseas have also entered the market. As domestic companies focusing mainly on original drugs have also started to strengthen their generic drug business, the competitive ...

Company Report: Generic Drug In Asia For Year 2012

Company Report: Generic Drug In Japan For Year 2012

... As of 2012.06.15 We are pleased to announce that the 15th annual conference of the international generic pharmaceutical alliance (igpa) will be held under the theme: generic medicines for better access ...

Company Report: Generic Drug In Japan For Year 2012

... Because of slowing economic growth in china and other emerging countries and other issues. In japan S ethical drug industry, the government is continuing to work on promoting the use of generic drugs ...

Generic Drug Sector In Japan

... For stable supply of generics as for compliance with the stable supply of generics, mhlw has set three requirements for generic medicines companies in 2006: At least five-year supply continuity ...

The Japanese Generic Drug Industry

... Of japan society of generic medicines a range of activities to promote the wider acceptance of generics in japan, including (1) research on quality, information, and supply structures (2) international ...

Generic Drug Market In Japan

... Measures were established in the revision of medical service fee of april 2012. Since patients will be provided at pharmacies with written information about the availability of generic drugs and the price ...